CoChat

Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer

Open access

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Abstract

Intestinal gastric cancer (IGC) carcinogenesis results from a complex interplay between environmental and molecular factors, ultimately contributing to disease development. We used integrative bioinformatic analysis to investigate IGC high-throughput molecular data to uncover interactions among differentially expressed genes, microRNAs, and proteins and their roles in IGC. An integrated network was generated based on experimentally validated microRNA-gene/protein interaction data, with three regulatory circuits involved in a complex network contributing to IGC progression. Key regulators were determined, including 23 microRNA and 15 gene/protein hubs. The regulatory circuit networks were associated with hallmarks of cancer, e.g., cell death, apoptosis and the cell cycle, the immune response, and epithelial-to-mesenchymal transition, indicating that different mechanisms of gene regulation impact similar biological functions. Altered expression of hubs was related to the clinicopathological characteristics of IGC patients and showed good performance in discriminating tumors from adjacent nontumor tissues and in relation to T stage and overall survival (OS). Interestingly, expression of upregulated hub hsa-mir-200b and its downregulated target hub gene/protein CFL2 were related not only to pathological T staging and OS but also to changes during IGC carcinogenesis. Our study suggests that regulation of CFL2 by hsa-miR-200b is a dynamic process during tumor progression and that this control plays essential roles in IGC development. Overall, the results indicate that this regulatory interaction is an important component in IGC pathogenesis. Also, we identified a novel molecular interplay between microRNAs, proteins, and genes associated with IGC in a complex biological network and the hubs closely related to IGC carcinogenesis as potential biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers15225374

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design. Data from tumor tissues and adjacent nontumor tissue controls from IGC were obtained from the TCGA database. Differential expression analysis of DEMs and DEGs was performed. The DEGs were compared with the DEPs from our previous study. Common identifications were used as guides for construction of a network with integration of validated DEM interaction data, resulting in the construction of three networks regarded as regulatory circuits. The list of identifications was subjected to functional enrichment analyses, and the hubs for each circuit were identified. Finally, the impact of hub expression on IGC carcinogenesis was evaluated. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 1 Study design. Data from tumor tissues and adjacent nontumor tissue controls from IGC were obtained from the TCGA database. Differential expression analysis of DEMs and DEGs was performed. The DEGs were compared with the DEPs from our previous study. Common identifications were used as guides for construction of a network with integration of validated DEM interaction data, resulting in the construction of three networks regarded as regulatory circuits. The list of identifications was subjected to functional enrichment analyses, and the hubs for each circuit were identified. Finally, the impact of hub expression on IGC carcinogenesis was evaluated. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 2 Differential gene expression analysis of genes and miRNAs of IGC patients from the TCGA-STAD dataset. (A) Volcano plot of mRNAs in IGC patients. (B) Volcano plot of microRNAs in IGC patients. The y-axis represents the negative base 10 logarithm of the adjusted p value, and the x-axis represents the log2−fold change. An adjusted p value ≤ 0.05 and |log2FC| ≥ 1 were considered indicative of differential expression for DEG selection; an adjusted p value ≤ 0.05 and |log2FC| > 0 were applied to select DEMs. The red dots correspond to individual DEGs (A) and DEMs (B) with significant expression differences (combining p value and log2FC cutoff) (24.73% for DEGs and 22.7% for DEMs). The green dots correspond to mRNAs or microRNAs that reached the minimum value of log2FC but not the p value (1.55% for DEGs and 77.3% for DEMs). The blue dots correspond to mRNAs or microRNAs that reached the minimum p value but not log2FC (36.64% for DEGs and none for DEMs). The gray dots correspond to nonsignificant mRNAs or microRNAs (37.07% for DEGs and none for DEMs). IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 2 Differential gene expression analysis of genes and miRNAs of IGC patients from the TCGA-STAD dataset. (A) Volcano plot of mRNAs in IGC patients. (B) Volcano plot of microRNAs in IGC patients. The y-axis represents the negative base 10 logarithm of the adjusted p value, and the x-axis represents the log2−fold change. An adjusted p value ≤ 0.05 and |log2FC| ≥ 1 were considered indicative of differential expression for DEG selection; an adjusted p value ≤ 0.05 and |log2FC| > 0 were applied to select DEMs. The red dots correspond to individual DEGs (A) and DEMs (B) with significant expression differences (combining p value and log2FC cutoff) (24.73% for DEGs and 22.7% for DEMs). The green dots correspond to mRNAs or microRNAs that reached the minimum value of log2FC but not the p value (1.55% for DEGs and 77.3% for DEMs). The blue dots correspond to mRNAs or microRNAs that reached the minimum p value but not log2FC (36.64% for DEGs and none for DEMs). The gray dots correspond to nonsignificant mRNAs or microRNAs (37.07% for DEGs and none for DEMs). IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 3 Overlap identification between DEGs and DEPs. Common findings (DEGs/DEPs) were segregated into four main groups. (A) Comparison between downregulated DEGs and downregulated DEPs. (B) Comparison between upregulated DEGs and upregulated DEPs. (C) Comparison between upregulated DEGs and downregulated DEPs. (D) Comparison between downregulated DEGs and upregulated DEPs. DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 3 Overlap identification between DEGs and DEPs. Common findings (DEGs/DEPs) were segregated into four main groups. (A) Comparison between downregulated DEGs and downregulated DEPs. (B) Comparison between upregulated DEGs and upregulated DEPs. (C) Comparison between upregulated DEGs and downregulated DEPs. (D) Comparison between downregulated DEGs and upregulated DEPs. DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 4 Interaction network and enrichment analysis regarding the first repressive regulatory circuit (RRC1) of DEMs and DEGs/DEPs in IGC. (A) RRC1 is defined by a network involving 399 interactions between upregulated DEMs (199) targeting downregulated DEGs/DEPs (48). Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C) DEG/DEP enrichment analysis performed using the Enrichr tool software version 3.2. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 4 Interaction network and enrichment analysis regarding the first repressive regulatory circuit (RRC1) of DEMs and DEGs/DEPs in IGC. (A) RRC1 is defined by a network involving 399 interactions between upregulated DEMs (199) targeting downregulated DEGs/DEPs (48). Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C) DEG/DEP enrichment analysis performed using the Enrichr tool software version 3.2. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 5 Interaction network and enrichment analysis regarding the second repressive regulatory circuit (RRC2) of DEMs and DEGs/DEPs in IGC. (A) RRC2 is defined by a network involving 86 interactions between upregulated DEMs targeting upregulated DEGs with downregulated DEPs. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression only shown regarding DEPs). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C). DEG/DEP enrichment analysis was performed using the KEGG database. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 5 Interaction network and enrichment analysis regarding the second repressive regulatory circuit (RRC2) of DEMs and DEGs/DEPs in IGC. (A) RRC2 is defined by a network involving 86 interactions between upregulated DEMs targeting upregulated DEGs with downregulated DEPs. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression only shown regarding DEPs). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C). DEG/DEP enrichment analysis was performed using the KEGG database. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 6 Interaction network and enrichment analysis regarding the third inductive regulatory circuit (IRC) of DEMs, DEGs, and DEPs in IGC. (A). IRC is defined by a network involving 73 interactions between downregulated DEMs targeting upregulated DEGs/DEPs. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C). DEG/DEP enrichment analysis was performed using the KEGG database. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 6 Interaction network and enrichment analysis regarding the third inductive regulatory circuit (IRC) of DEMs, DEGs, and DEPs in IGC. (A). IRC is defined by a network involving 73 interactions between downregulated DEMs targeting upregulated DEGs/DEPs. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression). Gray lines indicate inhibition. (B) DEM enrichment analysis performed using the TAM 2.0 software. (C). DEG/DEP enrichment analysis was performed using the KEGG database. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 7 ROC curve analysis of hubs. ROC curves were constructed using the easyROC software based on expression of hubs in tumor vs. adjacent nontumor tissue in TCGA-STAD IGC patients. ROC curves for DEM hubs of RRC1 (A), RRC2 (B), and IRC (C). ROC curves for DEG hubs of RRC1 (D), RRC2 (E), and IRC (F). IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.
Figure 7 ROC curve analysis of hubs. ROC curves were constructed using the easyROC software based on expression of hubs in tumor vs. adjacent nontumor tissue in TCGA-STAD IGC patients. ROC curves for DEM hubs of RRC1 (A), RRC2 (B), and IRC (C). ROC curves for DEG hubs of RRC1 (D), RRC2 (E), and IRC (F). IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.CC BY · PubMed Central
Figure 8 The association of hub expression with different tumor stages from 174 IGC patients in the TCGA cohort. DEMs and DEGs with significant associations are shown: DEMs (hsa-mir-200b, hsa-let-7d, hsa-mir-15b, hsa-mir-26b, and hsa-mir-1-1) and DEGs (CFL2 and SNRPD1). The Kruskal-Wallis test was applied for multiple group comparisons; the Mann-Whitney test was performed for pairwise comparisons. Differences were considered significant at p values ≤ 0.05. The pairwise comparison and resulting p value between individual stages are represented by horizontal bars. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.
Figure 8 The association of hub expression with different tumor stages from 174 IGC patients in the TCGA cohort. DEMs and DEGs with significant associations are shown: DEMs (hsa-mir-200b, hsa-let-7d, hsa-mir-15b, hsa-mir-26b, and hsa-mir-1-1) and DEGs (CFL2 and SNRPD1). The Kruskal-Wallis test was applied for multiple group comparisons; the Mann-Whitney test was performed for pairwise comparisons. Differences were considered significant at p values ≤ 0.05. The pairwise comparison and resulting p value between individual stages are represented by horizontal bars. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.CC BY · PubMed Central
Figure 9 Overall survival of patients stratified according to hub expression. Kaplan-Meier analysis showing the association between hub (hsa-mir-200b, hsa-mir-17, CFL2, and QSOX2) expression and overall survival (OS) in IGC patients from the TCGA cohort. High- and low-expression groups were divided according to expression quartiles, with the upper quartile representing the high group (red line) and the lower quartile representing the low group (black line). Only those with available survival data were included in the analysis.
Figure 9 Overall survival of patients stratified according to hub expression. Kaplan-Meier analysis showing the association between hub (hsa-mir-200b, hsa-mir-17, CFL2, and QSOX2) expression and overall survival (OS) in IGC patients from the TCGA cohort. High- and low-expression groups were divided according to expression quartiles, with the upper quartile representing the high group (red line) and the lower quartile representing the low group (black line). Only those with available survival data were included in the analysis.CC BY · PubMed Central
Figure 10 Interactive network of hubs. The regulatory interaction between all 23 DEM and 15 DEG/DEP hubs is shown. Red shaded rectangle in IRC and blue shaded rectangle in IRC1 represent DEM–DEG pairs contributing to clinical outcomes. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression only shown regarding DEPs). Gray lines indicate inhibition. RRC1 = first repressive regulatory circuit; RRC2 = second repressive regulatory circuit IRC = inductive regulatory circuit; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.
Figure 10 Interactive network of hubs. The regulatory interaction between all 23 DEM and 15 DEG/DEP hubs is shown. Red shaded rectangle in IRC and blue shaded rectangle in IRC1 represent DEM–DEG pairs contributing to clinical outcomes. Ellipses represent DEGs/DEPs, and diamond forms represent DEMs. Expression node levels are presented by the colors red (increased expression) and blue (decreased expression only shown regarding DEPs). Gray lines indicate inhibition. RRC1 = first repressive regulatory circuit; RRC2 = second repressive regulatory circuit IRC = inductive regulatory circuit; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes; DEPs = differentially expressed proteins.CC BY · PubMed Central
Figure 11 Scatter plots representing correlations among DEM and target DEG hubs in 180 IGC patients of the TCGA cohort. (A) hsa-mir-26b and SNRPD1. (B) hsa-mir-1-1 and SNRPD1. (C) hsa-mir-200b and CFL2. The analysis was performed by Pearson’s correlation, where inverse correlations were considered significant at p ≤ 0.05, R ≤ − 0.3. The blue line represents the regression line, and the gray shading represents the 95% confidence interval. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.
Figure 11 Scatter plots representing correlations among DEM and target DEG hubs in 180 IGC patients of the TCGA cohort. (A) hsa-mir-26b and SNRPD1. (B) hsa-mir-1-1 and SNRPD1. (C) hsa-mir-200b and CFL2. The analysis was performed by Pearson’s correlation, where inverse correlations were considered significant at p ≤ 0.05, R ≤ − 0.3. The blue line represents the regression line, and the gray shading represents the 95% confidence interval. IGC = intestinal gastric cancer; DEMs = differentially expressed microRNAs; DEGs = differentially expressed genes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Cited by

See all 3

Metadata

Authors
dos Santos, E. C., Rohan, P., Binato, R., & Abdelhay, E.
Affiliations
Instituto Nacional de Câncer - INCA (BR)
Corresponding author
dos Santos, Everton Cruz
Venue
Cancers
Publisher
MDPI AG
Published
2023-11-12
Volume
15
Issue
22
Pages
5374
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4388637464
Cited by
3
References
85
Citations by year
2026: 2 · 2024: 1
FWCI
0.38
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/202.981/2016, SEI-260003/001147/2020, 303479/2015)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (E-26/202.981/2016, SEI-260003/001147/2020, 303479/2015)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
regulatory networks, hub genes, tumor progression, T staging, overall survival, prognostic factors, carcinogenesis, epithelial-mesenchymal transition, cancer hallmarks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.